Electromed (ELMD) Change in Account Payables (2021 - 2023)
Electromed (ELMD) reported Change in Account Payables of -$349000.0 for Q1 2023, down 353.25% year-over-year from $137810.3 in Q1 2022, and down 237.4% on a QoQ basis from $254000.0 in Q4 2022.
Electromed (ELMD) has 3 years of Change in Account Payables data on file, last reported at -$349000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -349,000.00 |
| Mar 31, 2023 | -349,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Sep 30, 2022 | -175,000.00 |
| Mar 31, 2022 | -77,000.00 |
| Mar 31, 2022 | -77,000.00 |
| Dec 31, 2021 | 132,000.00 |
| Dec 31, 2021 | 132,000.00 |
| Sep 30, 2021 | -498,000.00 |
| Sep 30, 2021 | -498,000.00 |